352 related articles for article (PubMed ID: 16855369)
1. Molecular basis of fibrinogen deficiency.
Neerman-Arbez M
Pathophysiol Haemost Thromb; 2006; 35(1-2):187-98. PubMed ID: 16855369
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the fibrinogen gene cluster accounting for congenital afibrinogenemia: an update and report of 10 novel mutations.
Neerman-Arbez M; de Moerloose P
Hum Mutat; 2007 Jun; 28(6):540-53. PubMed ID: 17295221
[TBL] [Abstract][Full Text] [Related]
3. Congenital fibrinogen disorders: an update.
de Moerloose P; Casini A; Neerman-Arbez M
Semin Thromb Hemost; 2013 Sep; 39(6):585-95. PubMed ID: 23852822
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of congenital fibrinogen disorders.
Lebreton A; Casini A
Ann Biol Clin (Paris); 2016 Aug; 74(4):405-12. PubMed ID: 27492693
[TBL] [Abstract][Full Text] [Related]
5. Expression and analysis of a split premature termination codon in FGG responsible for congenital afibrinogenemia: escape from RNA surveillance mechanisms in transfected cells.
Neerman-Arbez M; Germanos-Haddad M; Tzanidakis K; Vu D; Deutsch S; David A; Morris MA; de Moerloose P
Blood; 2004 Dec; 104(12):3618-23. PubMed ID: 15284111
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of the fibrinogen gene cluster in 16 patients with congenital afibrinogenemia: novel truncating mutations in the FGA and FGG genes.
Neerman-Arbez M; de Moerloose P; Honsberger A; Parlier G; Arnuti B; Biron C; Borg JY; Eber S; Meili E; Peter-Salonen K; Ripoll L; Vervel C; d'Oiron R; Staeger P; Antonarakis SE; Morris MA
Hum Genet; 2001 Mar; 108(3):237-40. PubMed ID: 11354637
[TBL] [Abstract][Full Text] [Related]
7. Congenital fibrinogen disorder caused by digenic mutations of the
Wang X; Tang N; Shen N; Lu Y; Li D
Hematology; 2020 Dec; 25(1):145-148. PubMed ID: 32228225
[No Abstract] [Full Text] [Related]
8. The molecular basis of inherited afibrinogenaemia.
Neerman-Arbez M
Thromb Haemost; 2001 Jul; 86(1):154-63. PubMed ID: 11487003
[TBL] [Abstract][Full Text] [Related]
9. Laboratory and Genetic Investigation of Mutations Accounting for Congenital Fibrinogen Disorders.
Neerman-Arbez M; de Moerloose P; Casini A
Semin Thromb Hemost; 2016 Jun; 42(4):356-65. PubMed ID: 27019463
[TBL] [Abstract][Full Text] [Related]
10. Rare inherited disorders of fibrinogen.
Acharya SS; Dimichele DM
Haemophilia; 2008 Nov; 14(6):1151-8. PubMed ID: 19141154
[TBL] [Abstract][Full Text] [Related]
11. Congenital afibrinogenemia: Identification and characterization of two novel homozygous fibrinogen Aα and Bβ chain mutations in two Tunisian families.
Amri Y; Toumi Nel H; Hadj Fredj S; de Moerloose P
Thromb Res; 2016 Jul; 143():11-6. PubMed ID: 27164460
[TBL] [Abstract][Full Text] [Related]
12. [Congenital afibrinogenemia caused by a novel insertion mutation in the FGB gene].
Zhang J; Zhao XJ; Wang ZY; Yu ZQ; Cao LJ; Ma ZN; Zhang J; Zhang W; Bai X; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):751-6. PubMed ID: 24103871
[TBL] [Abstract][Full Text] [Related]
13. Genetic and clinical characterization of congenital fibrinogen disorders in Polish patients: Identification of three novel fibrinogen gamma chain mutations.
Wypasek E; Klukowska A; Zdziarska J; Zawilska K; Treliński J; Iwaniec T; Mital A; Pietrys D; Sydor W; Neerman-Arbez M; Undas A
Thromb Res; 2019 Oct; 182():133-140. PubMed ID: 31479941
[TBL] [Abstract][Full Text] [Related]
14. Congenital hypofibrinogenemia: characterization of two missense mutations affecting fibrinogen assembly and secretion.
Platè M; Asselta R; Spena S; Spreafico M; Fagoonee S; Peyvandi F; Tenchini ML; Duga S
Blood Cells Mol Dis; 2008; 41(3):292-7. PubMed ID: 18676163
[TBL] [Abstract][Full Text] [Related]
15. Quality control of fibrinogen secretion in the molecular pathogenesis of congenital afibrinogenemia.
Vu D; Di Sanza C; Caille D; de Moerloose P; Scheib H; Meda P; Neerman-Arbez M
Hum Mol Genet; 2005 Nov; 14(21):3271-80. PubMed ID: 16195396
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen gene mutations accounting for congenital afibrinogenemia.
Neerman-Arbez M
Ann N Y Acad Sci; 2001; 936():496-508. PubMed ID: 11460507
[TBL] [Abstract][Full Text] [Related]
17. Mutations Accounting for Congenital Fibrinogen Disorders: An Update.
Richard M; Celeny D; Neerman-Arbez M
Semin Thromb Hemost; 2022 Nov; 48(8):889-903. PubMed ID: 35073585
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of 7 patients affected by dys- or hypo-dysfibrinogenemia: Identification of a novel mutation in the fibrinogen Bbeta chain causing a gain of glycosylation.
Asselta R; Robusto M; Platé M; Santoro C; Peyvandi F; Duga S
Thromb Res; 2015 Jul; 136(1):168-74. PubMed ID: 26006300
[TBL] [Abstract][Full Text] [Related]
19. The molecular basis of quantitative fibrinogen disorders.
Asselta R; Duga S; Tenchini ML
J Thromb Haemost; 2006 Oct; 4(10):2115-29. PubMed ID: 16999847
[TBL] [Abstract][Full Text] [Related]
20. Congenital fibrinogen disorder with a compound heterozygote possessing two novel FGB mutations, one qualitative and the other quantitative.
Yoda M; Kaido T; Taira C; Higuchi Y; Arai S; Okumura N
Thromb Res; 2020 Dec; 196():152-158. PubMed ID: 32871307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
